argenx
Andria Wilk joined argenx as Global Head of Quality Assurance (QA) in January 2020. She has more than 20 years of experience in QA within the pharmaceutical industry. Most recently, Andria served as Senior Director, Head of Medical, Regulatory & Clinical QA (MRC QA) at Lundbeck, where she managed the global MRC QA group based in the EU, US and Asia.
In this role, she was responsible for the global audit programmes and QA support for all clinical trial and post-marketing activities and related computerized systems. Prior to Lundbeck, she held various QA positions of increasing responsibility within AstraZeneca, Takeda Global Research and Development (TGRD) and Astellas Pharmaceuticals.
Andria holds a joint B.Sc. in Pharmacology and Biochemistry and is a member of Research Quality Association (MRQA).
This person is not in any offices
argenx
31 followers
Argenx discovers, designs and develops innovative antibody therapeutics for its own pipeline of treatments for cancer and autoimmune diseases and for its partners. Harnessing our technology and know-how, we aim to meet the needs of patients by engineer...